Rory Nealon

Chief Financial Officer and Chief Operating Officer (CFO & COO)

Rory Nealon co-founded Amryt Pharma in August 2015. Prior to that, he was the Chief Financial Officer (from 2003), Chief Operating Officer (from November 2007) and Board Member of Trinity Biotech plc, a diagnostic company listed on Nasdaq. He has also been a Board Member and Chief Financial Officer of Conduit plc, an Irish directory services provider with operations in Ireland, the UK, Austria and Switzerland, as well as an Associate Director at AIB Capital Markets, a subsidiary of AIB Group plc, the Irish banking group. He holds a Bachelor of Commerce degree from University College Dublin, is a Fellow of the Institute of Chartered Accountants in Ireland, a member of the Institute of Taxation in Ireland and a member of the Institute of Corporate Treasurers in the UK.

Sheila Frame

President, Americas

Sheila Frame serves as President, Americas, where she is also a member of the Amryt Executive Committee. In her role, Sheila leads the overall business of Amryt across North and South America.

Sheila brings with her more than 20 years of pharmaceutical experience leading functions and businesses in the United States, Canada and the Nordics. Most of her career has been in the specialty businesses of immunology, immuno-oncology and epilepsy. Prior to Amryt, Sheila held several Worldwide Commercial and country General Management roles with Novartis and Bristol Myers Squibb where she led the commercialization and launch efforts for in line and pipeline assets, including Tabrecta®, Orencia®, Yervoy® and the PDL1 diagnostic for Opdivo®. Before joining the pharmaceutical industry, Sheila began her professional career holding senior positions with the Government of Canada before moving to industry as a lobbyist and an expert in pharmaceutical policy and reimbursement. .

Sheila is currently the past-President of the Central New Jersey Chapter of the Healthcare Businesswomen’s Association. She is also a non-executive director of Theratechnologies Inc. Sheila was recognized as a 2019 Woman of Inspiration & Influence by the Women Business Leaders of the US Health Care Industry Foundation.

Sheila holds a Bachelor of Arts degree from York University and a Masters of Business Administration degree from Concordia University.

David Allmond

Chief Commercial Officer (CCO)

David Allmond joined Amryt Pharma as Chief Commercial Officer in March 2017. Prior to joining Amryt, he was President Europe, Middle East and Africa (EMEA) at Aegerion Pharmaceuticals, where he was responsible for the commercialisation of Lojuxta (lomitapide), a treatment for Homozygous Familial Hypercholesterolemia (HoFH) recently in-licensed by Amryt Pharma. Mr. Allmond was previously Corporate Vice President of Global Marketing at Celgene, where he played a pivotal role in defining strategy for in-line brands, lifecycle/pipeline prioritisation and commercial direction for business development. He was also responsible for EMEA marketing and market access.

Dr. Helen Phillips

Head of Medical Affairs

Dr Helen Phillips joined Amryt Pharma in December 2016. Prior to joining, she was Medical Director EMEA at Aegerion Pharmaceuticals, where she was responsible for the medical activities supporting Lojuxta (lomitapide), a treatment for Homozygous Familial Hypercholesterolaemia (HoFH). Dr. Phillips has over 20 years’ experience in Medical Affairs, working in UK, European and Global roles for AstraZeneca, GSK and Hospira, as well as biotech start-up companies, Aspreva and Vanda. She has a degree in Medicine from Bristol University Medical School and spent six years in the NHS in General Practice.

Derval O’Carroll

Head of Regulatory Affairs

Derval has over 25 years’ experience in pharmaceutical industry regulatory affairs. Prior to joining Amryt, Derval was Senior Director of Regulatory Affairs for the NASDAQ‐listed rare diseases company Retrophin Inc., where she provided regulatory, strategic and operational input to product teams managing Retrophin’s development‐stage and commercial products. Before that, Derval worked for 11 years as a Managing Consultant at Real Regulatory Ltd, a consultancy specialising in European regulatory affairs, quality management systems and supply chain operations compliance

Stephen Joyce

VP, Global Marketing

Stephen joined Amryt Pharma as VP, Global Marketing in December 2018 with over 15 years’ experience in the pharmaceutical industry across multiple therapy areas. Most recently Stephen was General Manager, Switzerland at Astellas Pharmaceuticals AG, and prior to that he was Area Marketing & Market Access Director at Astellas Pharma EMEA. During this time, he played a pivotal role in multiple product launches, redefining portfolio and brand strategies, and multiple organisational change projects, whilst contributing to development of a new operating model for the EMEA region. He holds a BSc. in Marketing from Trinity College Dublin and has participated in the INSEAD Executive Leadership Programme.

Gerry Gilligan

Head of Manufacturing Supply Chain

Gerry has over 25 years’ experience in the pharmaceutical sector. His experience has spanned Supply chain, API, Development, Solid Oral dosage, Semi Solid formulations, Bulk Manufacturing and Aseptic fill finish. He joined Amryt in February 2019. His most recent rolls have included Director of Manufacturing, Director of Operations and Site Lead at LEO Pharma. Gerry has a PhD in Chemistry, Black belt in Lean/ Quality Systems and most recently became a certified Business Coach. He has led organisations through significant operational transformation and been involved in acquisitions of companies and product portfolios.

Elizabeth V. Jobes JD

Senior Vice President, Global Chief Compliance Officer

Elizabeth has over 30 years of experience as an attorney and compliance professional in the life sciences industry. Before joining Amryt in January 2020, she held the position of Senior Vice President and Chief Compliance Officer Americas for EMD Serono (Greater Boston) a division of Merck KGaA. Prior to that, she held the roles of Head of Global Compliance, Spark Therapeutics a gene therapy company based in Philadelphia, Pennsylvania. Before joining Spark, Elizabeth held positions as Chief Compliance officer at Auxilium Pharmaceuticals and Adolor Pharmaceuticals, as well as a senior compliance role at Cephalon Inc. She began her career as a trial attorney with the Philadelphia District Attorney’s office and then supervised several divisions within that office before moving to the pharmaceutical industry. Elizabeth received her BA from Pennsylvania State University and was a Patricia Harris Fellow at Rutgers University School of Law where she received her JD.

John McEvoy

General Counsel

John McEvoy has served as Amryt’s General Counsel from September 2017. Mr. McEvoy oversees all legal, corporate affairs and data protection matters globally for Amryt. Prior to joining Amryt, he served as a lawyer in private practice with Arthur Cox, one of Ireland’s top-tier law firms, and Herbert Smith Freehills, one of the UK’s elite corporate law firms. Mr McEvoy is a qualified lawyer in the U.S. (New York), England and Wales, and Ireland and has represented leading multinational public and private companies in transactions across North America, Europe, and Asia and has experience in many industries including Corporate M&A, Life Sciences, Technology, Media and Telecoms and Data Protection. He holds an LLB from Queens University Belfast and is a member of the American Bar Association, Law Society of England and Wales and Law Society of Ireland.